Total Payments
$3,923
2024 Payments
$826.29
Companies
29
Transactions
112
Medicare Patients
3,004
Medicare Billing
$277,745
Payment Breakdown by Category
Food & Beverage$3,857 (98.3%)
Other$66.68 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,857 | 111 | 98.3% |
| Entertainment | $66.68 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb Americas Inc. | $439.20 | 10 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $394.30 | 16 | $0 (2024) |
| Alcon Vision LLC | $369.21 | 12 | $0 (2024) |
| ABBVIE INC. | $364.70 | 9 | $0 (2024) |
| Oyster Point Pharma, Inc. | $307.80 | 11 | $0 (2024) |
| Horizon Therapeutics plc | $250.72 | 3 | $0 (2023) |
| BIOTISSUE HOLDINGS INC. | $205.22 | 4 | $0 (2024) |
| Aerie Pharmaceuticals, Inc. | $178.13 | 4 | $0 (2021) |
| Kala Pharmaceuticals, Inc. | $172.58 | 3 | $0 (2022) |
| Carl Zeiss Meditec, Inc. | $122.98 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $826.29 | 26 | SUN PHARMACEUTICAL INDUSTRIES INC. ($204.28) |
| 2023 | $1,345 | 35 | Oyster Point Pharma, Inc. ($273.83) |
| 2022 | $870.79 | 23 | Alcon Vision LLC ($278.93) |
| 2021 | $142.13 | 7 | SUN PHARMACEUTICAL INDUSTRIES INC. ($36.16) |
| 2020 | $137.70 | 2 | Aerie Pharmaceuticals, Inc. ($116.36) |
| 2019 | $243.50 | 7 | Shire North American Group Inc ($122.76) |
| 2018 | $208.21 | 6 | Carl Zeiss Meditec, Inc. ($122.98) |
| 2017 | $149.86 | 6 | Optos, Inc. ($66.68) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: EYE CARE | ||||||
| 10/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Ophthalmology | ||||||
| 09/19/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: EYE CARE | ||||||
| 09/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Ophthalmology | ||||||
| 08/22/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Dry eyes | ||||||
| 08/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Ophthalmology | ||||||
| 07/30/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: OPTOMETRY | ||||||
| 06/25/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/11/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: SOLUTION/ DROPS | ||||||
| 06/03/2024 | Bausch & Lomb Americas Inc. | enVista MX60 IOL (Device) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Ophthalmology | ||||||
| 05/14/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Ophthalmology | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.04 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 04/22/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Ophthalmology | ||||||
| 04/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $119.70 | General |
| Category: Ophthalmology | ||||||
| 03/18/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $119.92 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: EYE CARE | ||||||
| 02/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $103.32 | General |
| Category: Ophthalmology | ||||||
| 02/06/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $25.82 | General |
| 01/08/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $20.27 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 915 | 1,149 | $158,014 | $85,928 |
| 2022 | 15 | 1,050 | 1,222 | $202,702 | $91,949 |
| 2021 | 13 | 794 | 1,085 | $189,565 | $83,859 |
| 2020 | 7 | 245 | 295 | $40,690 | $16,009 |
Total Patients
3,004
Total Services
3,751
Medicare Billing
$277,745
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 198 | 219 | $38,982 | $22,359 | 57.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 162 | 293 | $36,625 | $21,626 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 97 | 97 | $22,795 | $12,497 | 54.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 24 | $22,440 | $11,915 | 53.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 68 | 71 | $6,745 | $3,513 | 52.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 96 | 118 | $7,552 | $3,353 | 44.4% |
| 92134 | Imaging of retina | Office | 2023 | 70 | 78 | $5,148 | $2,363 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 31 | $4,650 | $2,214 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $3,600 | $1,810 | 50.3% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 23 | 36 | $3,060 | $1,362 | 44.5% |
| 92250 | Photography of the retina | Office | 2023 | 33 | 33 | $2,310 | $1,081 | 46.8% |
| 92025 | Ct scan of cornea | Office | 2023 | 18 | 20 | $1,120 | $640.95 | 57.2% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 61 | 79 | $1,817 | $632.30 | 34.8% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 27 | 30 | $1,170 | $560.56 | 47.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 254 | 319 | $68,510 | $28,510 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $22,250 | $11,180 | 50.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 100 | 100 | $17,920 | $10,960 | 61.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 16 | 21 | $30,285 | $10,594 | 35.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 95 | 125 | $15,955 | $10,277 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 73 | $11,055 | $5,421 | 49.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 76 | 76 | $7,530 | $4,132 | 54.9% |
| 92133 | Imaging of optic nerve | Office | 2022 | 109 | 112 | $7,685 | $3,358 | 43.7% |
| 92134 | Imaging of retina | Office | 2022 | 52 | 54 | $3,956 | $1,876 | 47.4% |
| 92250 | Photography of the retina | Office | 2022 | 60 | 60 | $5,361 | $1,797 | 33.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 20 | 45 | $6,425 | $1,722 | 26.8% |
About Dr. Lamees Ashker, M.D
Dr. Lamees Ashker, M.D is a Ophthalmology healthcare provider based in Riverdale, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790908051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lamees Ashker, M.D has received a total of $3,923 in payments from pharmaceutical and medical device companies, with $826.29 received in 2024. These payments were reported across 112 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,857).
As a Medicare-enrolled provider, Ashker has provided services to 3,004 Medicare beneficiaries, totaling 3,751 services with total Medicare billing of $277,745. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Riverdale, MD
- Active Since 04/11/2007
- Last Updated 03/18/2011
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1790908051
Products in Payments
- Cequa (Drug) $372.33
- TYRVAYA (Drug) $307.80
- TEPEZZA (Drug) $250.72
- Clareon (Device) $228.21
- VYZULTA (Drug) $185.80
- PROKERA (Device) $184.95
- XIIDRA (Drug) $176.37
- INVELTYS (Drug) $172.58
- LUMIGAN (Drug) $171.76
- MIEBO (Drug) $125.72
- CIRRUS HD-OCT (Device) $122.98
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $119.92
- Syfovre (Drug) $116.74
- rocklatan (Drug) $116.36
- DURYSTA (Drug) $115.30
- Omidria (Drug) $107.67
- XDEMVY (Drug) $92.07
- California (Device) $66.68
- OXERVATE (Drug) $59.32
- ACTHAR (Biological) $46.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Riverdale
Dr. John Miller, Md, MD
Ophthalmology — Payments: $65,934
Ophthalmology $65,934
Dr. Michael Summerfield, M.d, M.D
Ophthalmology — Payments: $46,360
Ophthalmology $46,360
Deborah Wilson, M.d, M.D
Ophthalmology — Payments: $7,831
Ophthalmology $7,831
Dr. Ricardo Akstein, M.d, M.D
Ophthalmology — Payments: $4,677
Ophthalmology $4,677
Mr. Paul Goodman
Ophthalmology — Payments: $508.38
Ophthalmology $508.38
Shelly Belson, M.d, M.D
Ophthalmology — Payments: $493.36
Ophthalmology $493.36